Sulfalene
From Infogalactic: the planetary knowledge core
![]() |
|
Systematic (IUPAC) name | |
---|---|
4-Amino-N-(3-methoxypyrazinyl)benzenesulfonamide
|
|
Clinical data | |
Trade names | Eadazine, Kelfizina, Kelfizine W, Longum |
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral[1] |
Pharmacokinetic data | |
Protein binding | 60 to 80%[1] |
Biological half-life | 60 to 65 hours[1] |
Excretion | Urinary[1] |
Identifiers | |
CAS Number | 152-47-6 ![]() |
ATC code | J01ED02 (WHO) QJ01EQ19 (WHO) |
PubChem | CID: 9047 |
DrugBank | DB00664 ![]() |
ChemSpider | 8695 ![]() |
UNII | T6BL4ZC15G ![]() |
KEGG | D01216 ![]() |
Synonyms | Sulfametopyrazine |
Chemical data | |
Formula | C11H12N4O3S |
Molecular mass | 280.304 g/mol |
|
|
|
|
(verify) |
Sulfalene (INN, USAN) or sulfametopyrazine (BAN) is a long-acting sulfonamide antibacterial used for the treatment of chronic bronchitis, urinary tract infections and malaria.[2][3] As of 2014 there were only two countries in which it is currently still marketed: Thailand and Ireland.[3]
It was discovered by researchers at Farmitalia and first published in 1960 and was marketed as Kelfizina.[4][5]
See also
References
- ↑ 1.0 1.1 1.2 1.3 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ DrugBank DB00664
- ↑ 3.0 3.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Baruffa G. Clinical trials in Plasmodium falciparum malaria with a long-acting sulphonamide. Trans R Soc Trop Med Hyg. 1966;60(2):222-4. PMID 5332105
- ↑ Per prior citation, the first publication: Camerino B, Palamidessi G (1960) Derivati della parazina II. Sulfonamdopir (in Italian). Gazz Chim Ital 90:1802–1815
<templatestyles src="Asbox/styles.css"></templatestyles>